Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.070
+0.260 (14.36%)
At close: Oct 20, 2026, 4:00 PM EDT
2.070
0.00 (0.00%)
Pre-market: Oct 21, 2026, 4:39 AM EDT
BDTX Revenue
In the year 2025, Black Diamond Therapeutics had annual revenue of $70.00M. That makes Black Diamond Therapeutics the 25,410th largest company in the world by revenue and 3,532nd in the United States.
Revenue (ttm)
$70.00M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
118.93M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 70.00M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Tonix Pharmaceuticals Holding | 29.10M |
| LENZ Therapeutics | 21.48M |
| Coya Therapeutics | 8.02M |
| Cibus | 4.35M |
| Milestone Pharmaceuticals | 2.34M |
| Kazia Therapeutics | 1.27M |
| Inovio Pharmaceuticals | 65.34K |
BDTX News
- 5 weeks ago - Black Diamond Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 6 weeks ago - Black Diamond Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - Raymond James keeps Outperform rating on Black Diamond Therapeutics after Q2 - TheFly
- 2 months ago - Black Diamond Therapeutics setup ‘attractive,’ says Jefferies - TheFly
- 2 months ago - Black Diamond Therapeutics reports Q2 EPS (17c), consensus (20c) - TheFly
- 2 months ago - Black Diamond Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Black Diamond Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - Black Diamond Therapeutics Earnings release: Q2 2026 - Filings